Rocket Pharmaceuticals Inc
(NAS:RCKT)
$
16.41
0.34 (2.12%)
Market Cap: 1.49 Bil
Enterprise Value: 1.24 Bil
PE Ratio: 0
PB Ratio: 3.88
GF Score: 38/100 Rocket Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript
Sep 10, 2020 / 05:30PM GMT
Release Date Price:
$23.68
(-1.21%)
Mohit Bansal
Citigroup Inc. Exchange Research - Research Analyst
Great. Good afternoon. Thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the biotech analysts here at Citi, and I have a pleasure to have Gaurav Shah from Rocket. He's the CEO of the company with us. Thank you, Gaurav, for joining us today.
Gaurav Shah
Rocket Pharmaceuticals, Inc. - CEO, President & Director
My pleasure, Mohit.
Mohit Bansal
Citigroup Inc. Exchange Research - Research Analyst
Great.
Gaurav Shah
Rocket Pharmaceuticals, Inc. - CEO, President & Director
Good to see you and thanks for having us today.
Mohit Bansal
Citigroup Inc. Exchange Research - Research Analyst
Thank you. And those who can see us, you can see that Gaurav is sitting right next to fireside. So we are having a fireside chat today, literally. So I hope you enjoy the conversation.
(Operator Instructions)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot